|
Cutting Edge Cancer Care: The Latest on STI-571
|
Borkowsky, Ariel
Participants:
Brian J. Druker, MD ; Director, Leukemia Center at Oregon Health Sciences University
Charles L. Sawyers, MD ; UCLA Jonsson Cancer Center , Los Angeles, CA
Charles Schiffer, MD ; Karmanos Cancer Institute , Detroit, Michigan
With its recent FDA approval, STI-571 was a hot topic at this year's meeting of the American Society of Clinical Oncology. Designed specifically for chronic myeloid leukemia, it takes a novel, targeted approach to killing cancer cells. But though it has been approved, it is still under investigation. We talked to leading experts at the ASCO meeting to get the most up-to-date information.
Click here to view webcast:
Cutting Edge Cancer Care: The Latest on STI-571
|
|
|
|